Biomarkers for Diagnosis of Axial Spondyloarthritis, Disease Activity, Prognosis, and Prediction of Response to Therapy
There exists a major unmet need for biomarkers that can identify axial spondyloarthritis (axSpA) early after disease onset because of the availability of highly effective therapies. Several recent reports have examined the autoantibody response in patients with axSpA through the use of protein micro...
Main Author: | Walter P. Maksymowych |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00305/full |
Similar Items
-
Progression of axial spondyloarthritis
by: Sh. F. Erdes, et al.
Published: (2021-06-01) -
The Role of Imaging in Diagnosing Axial Spondyloarthritis
by: Nikita Khmelinskii, et al.
Published: (2018-04-01) -
ASSESSMENT OF COXITIS PROGRESSION IN EARLY AXIAL SPONDYLOARTHRITIS
by: E. M. Agafonova, et al.
Published: (2020-04-01) -
Ankylosing spondylitis and non-radiographic axial spondyloarthritis: Two stages of disease?
by: D G Rumyantseva, et al.
Published: (2017-05-01) -
A single center experience: physician related diagnostic delay and demographic and clinical differences between patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis
by: Ulutaş Firdevs, et al.
Published: (2021-09-01)